Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[tykundegex]

There is very, very little doubt this company is worth more than the market cap they have today, based ONLY on the 1 drug for which they're about to submit an NDA. They have successfully completed all clinical trials, arranged and completed all manufacturing and stability tests, and have a healthy patent protection for it. The only remaining question is how successful they can be in selling the drug when (not "if".. as it's a forgone conclusion IMO) the drug hits the shelves.

IMO, there is every likelihood this drug does annual sales equivalent to the current market cap, and a good chance it will do 5x or more than that.

How can they turn this into value for their shareholders? IMO, an acquisition would be best/cleanest. But they may simply license it and take a high % royalties, or they may even to at it alone (?).

From where I'm standing, all 3 scenarios will yield at least a 3x gain in share price over the next couple of years. With plenty more upside if they are acquired IMO.

Yes, keep being patient.